Protective Gene Variants
Geneticists are uncovering rare gene variants that protect against dementias by altering how the brain handles toxic proteins and lipids, Nature reported.
She launched her project in 2013. Since then, researchers have identified several genetic factors that shield the brain from cognitive decline.
The Genetics of Resilience
While most Alzheimer’s research focuses on high-risk genetic factors, scientists are increasingly investigating why certain individuals remain free of dementia despite carrying high-risk genes or heavy amyloid-beta plaque burdens. The brain possesses natural defense mechanisms against the toxic proteins that drive Alzheimer’s disease.
Familial early-onset Alzheimer’s accounts for less than 1% of all cases, typically appearing when individuals are in their 40s or 50s due to hereditary mutations. For late-onset cases affecting people over 65, the APOE gene serves as the primary genetic determinant.
APOE Alleles Regulate Lipid Transport and Disease Risk
The APOE gene regulates lipid transport between cells. Three main alleles create distinct risk profiles. APOE3 is the most common variant, while APOE4 increases disease risk and promotes protein aggregation. Conversely, APOE2 reduces risk, with two copies capable of delaying Alzheimer’s onset by a decade.
Beyond standard alleles, researchers have identified rare protective variants, as some recently discovered and rare variants seem to confer resistance. Neuroscientist Guojun Bu notes that nature has provided a blueprint for safe resistance, stating: Nature has already done the experiment for us: certain gene variants protect us from Alzheimer’s and they do so safely.
Understanding these mechanisms could lead to novel therapies.
Genomic Sequencing Advances
Large-scale genomic datasets have transformed the search for rare resilience genes. Resources such as the UK Biobank provide hundreds of thousands of genomes for analysis. Stanford University geneticist Michael Greicius emphasizes that analyzing larger populations increases the likelihood of spotting rare occurrences.
Ancestral diversity in data sets is critical for uncovering unique protective variants. Greicius’s team discovered a rare protective variant named W276C in a population with Native American ancestry, a variation absent in predominantly European cohorts.
Rare Protein Modifications
Laboratory tests on cell cultures and mouse models help scientists determine how tiny changes in protein structure alter disease biology. Biochemist Rosie Jackson explains that rare variants illuminate how common risk variants function.
Three rare variants identified in the APOE3 allele affect how the ApoE protein binds to molecules. One such variation, the Christchurch variant, alters the receptor-binding region to reduce the likelihood of tau protein spreading between cells.
Identifying Exact Mechanisms
Holstege, at Amsterdam University Medical Centre, says researchers must continue investigating how these variants operate: That’s why it is important to identify these variants and discover their exact mechanisms.
Worth a look